Understanding the evidence base for new therapies is critical for informed clinical practice. This module outlines the key efficacy and safety results from the phase 3 clinical trials of fezolinetant and elinzanetant, which resulted in their authorization by Health Canada for the management of VMS.
Summarizing the Efficacy and Safety Results of Fezolinetant and Elinzanetant
CAN-eng
$0
free
Unaccredited
7 min
Women's Health
0 Credits
Course Description
Course Details
Expiry Date: 2027-02-06
Professions: Physician, Nursing, Allied Health, Medical Resident, Student, Specialist
Faculty
Accreditation
Learning Objective(s)
After viewing this microlearning, participants will be better able to:
- Summarize the efficacy and safety results from trials of fezolinetant and elinzanetant